Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
1.930
-0.040 (-2.03%)
At close: Oct 26, 2026, 4:00 PM EDT
1.930
0.00 (0.00%)
After-hours: Oct 26, 2026, 4:04 PM EDT
Seer, Inc. Market Cap
Seer, Inc. has a market cap or net worth of $106.87 million as of October 26, 2026. It is the 24,526th most valuable company in the world and the 4,023rd biggest in the United States. Its market cap has decreased by 17.07% in one year.
Market Cap
106.87M
Enterprise Value
-23.60M
1-Year Change
-17.07%
Global Rank
Country Rank
#4,023 United States
Category
ChartMarket Cap Chart
Since the IPO on December 4, 2020, Seer, Inc.'s market cap has decreased from $3.27B to $106.87M, a decrease of -96.74%. That is a compound annual growth rate of -44.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 106.87M | 3.82% |
| Dec 31, 2025 | 102.94M | -24.43% |
| Dec 31, 2024 | 136.21M | 10.01% |
| Dec 29, 2023 | 123.82M | -65.92% |
| Dec 30, 2022 | 363.32M | -74.19% |
| Dec 31, 2021 | 1.41B | -57.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tiziana Life Sciences | 112.96M |
| Humacyte | 111.29M |
| NRx Pharmaceuticals | 110.32M |
| Kazia Therapeutics | 107.85M |
| Voyager Therapeutics | 107.83M |
| PolyPid | 107.45M |
| Cibus | 106.62M |
| enGene Therapeutics | 105.89M |